Aliaksandra Shymanskaya1, Wieland A Worthoff2, Gabriele Stoffels1, Johannes Lindemeyer1, Bernd Neumaier1, Philipp Lohmann1, Norbert Galldiks1,3,4, Karl-Josef Langen1,5,6, N Jon Shah1,6,7. 1. Institute of Neuroscience and Medicine (3, 4, 5, 11), Forschungszentrum Jülich GmbH, 52425, Jülich, Germany. 2. Institute of Neuroscience and Medicine (3, 4, 5, 11), Forschungszentrum Jülich GmbH, 52425, Jülich, Germany. w.worthoff@fz-juelich.de. 3. Department of Neurology, University of Cologne, Cologne, Germany. 4. Center of Integrated Oncology (CIO), Universities of Bonn and Cologne, Cologne, Germany. 5. Department of Nuclear Medicine, RWTH Aachen University, Aachen, Germany. 6. Jülich-Aachen Research Alliance (JARA) - Section JARA-Brain, Aachen, Germany. 7. Department of Neurology, RWTH Aachen University, Aachen, Germany.
Abstract
PURPOSE: Positron emission tomography (PET) using O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) improves the diagnostics of cerebral gliomas compared with conventional magnetic resonance imaging (MRI). Sodium MRI is an evolving method to assess tumor metabolism. In this pilot study, we explored the relationship of [18F]FET-PET and sodium MRI in patients with cerebral gliomas in relation to the mutational status of the enzyme isocitrate dehydrogenase (IDH). PROCEDURES: Ten patients with untreated cerebral gliomas and one patient with a recurrent glioblastoma (GBM) were investigated by dynamic [18F]FET-PET and sodium MRI using an enhanced simultaneous single-quantum- and triple-quantum-filtered imaging of 23Na (SISTINA) sequence to estimate total (NaT), weighted non-restricted (NaNR, mainly extracellular), and restricted (NaR, mainly intracellular) sodium in tumors and normal brain tissue. [18F]FET uptake and sodium parameters in tumors with a different IDH mutational status were compared. After biopsy or resection, histology and the IDH mutational status were determined neuropathologically. RESULTS: NaT (p = 0.05), tumor-to-brain ratios (TBR) of NaT (p = 0.02), NaNR (p = 0.003), and the ratio of NaT/NaR (p < 0.001) were significantly higher in IDH-mutated than in IDH-wild-type gliomas (n = 5 patients each) while NaR was significantly lower in IDH-mutated gliomas (p = 0.01). [18F]FET parameters (TBR, time-to-peak) were not predictive of IDH status in this small cohort of patients. There was no obvious relationship between sodium distribution and [18F]FET uptake. The patient with a recurrent GBM exhibited an additional radiation injury with strong abnormalities in sodium MRI. CONCLUSIONS: Sodium MRI appears to be more strongly related to the IDH mutational status than are [18F]FET-PET parameters. A further evaluation of the combination of the two methods in a larger group of high- and low-grade gliomas seems promising.
PURPOSE: Positron emission tomography (PET) using O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) improves the diagnostics of cerebral gliomas compared with conventional magnetic resonance imaging (MRI). Sodium MRI is an evolving method to assess tumor metabolism. In this pilot study, we explored the relationship of [18F]FET-PET and sodium MRI in patients with cerebral gliomas in relation to the mutational status of the enzyme isocitrate dehydrogenase (IDH). PROCEDURES: Ten patients with untreated cerebral gliomas and one patient with a recurrent glioblastoma (GBM) were investigated by dynamic [18F]FET-PET and sodium MRI using an enhanced simultaneous single-quantum- and triple-quantum-filtered imaging of 23Na (SISTINA) sequence to estimate total (NaT), weighted non-restricted (NaNR, mainly extracellular), and restricted (NaR, mainly intracellular) sodium in tumors and normal brain tissue. [18F]FET uptake and sodium parameters in tumors with a different IDH mutational status were compared. After biopsy or resection, histology and the IDH mutational status were determined neuropathologically. RESULTS:NaT (p = 0.05), tumor-to-brain ratios (TBR) of NaT (p = 0.02), NaNR (p = 0.003), and the ratio of NaT/NaR (p < 0.001) were significantly higher in IDH-mutated than in IDH-wild-type gliomas (n = 5 patients each) while NaR was significantly lower in IDH-mutated gliomas (p = 0.01). [18F]FET parameters (TBR, time-to-peak) were not predictive of IDH status in this small cohort of patients. There was no obvious relationship between sodium distribution and [18F]FET uptake. The patient with a recurrent GBM exhibited an additional radiation injury with strong abnormalities in sodium MRI. CONCLUSIONS:Sodium MRI appears to be more strongly related to the IDH mutational status than are [18F]FET-PET parameters. A further evaluation of the combination of the two methods in a larger group of high- and low-grade gliomas seems promising.
Authors: Manuel Röhrich; Kristin Huang; Daniel Schrimpf; Nathalie L Albert; Thomas Hielscher; Andreas von Deimling; Ulrich Schüller; Antonia Dimitrakopoulou-Strauss; Uwe Haberkorn Journal: Eur J Nucl Med Mol Imaging Date: 2018-05-07 Impact factor: 9.236
Authors: Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews Journal: Neuroimage Date: 2004 Impact factor: 6.556
Authors: Andriy M Babsky; Hong Zhang; Shahryar K Hekmatyar; Gary D Hutchins; Navin Bansal Journal: Magn Reson Imaging Date: 2007-01-04 Impact factor: 2.546
Authors: M Unterrainer; I Winkelmann; B Suchorska; A Giese; V Wenter; F W Kreth; J Herms; P Bartenstein; J C Tonn; N L Albert Journal: Eur J Nucl Med Mol Imaging Date: 2018-02-27 Impact factor: 9.236
Authors: Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith Journal: Neuroimage Date: 2011-09-16 Impact factor: 6.556
Authors: Marcus Unterrainer; Franziska Vettermann; Matthias Brendel; Adrien Holzgreve; Michael Lifschitz; Matthias Zähringer; Bogdana Suchorska; Vera Wenter; Ben M Illigens; Peter Bartenstein; Nathalie L Albert Journal: EJNMMI Res Date: 2017-05-30 Impact factor: 3.138
Authors: Chang-Hoon Choi; Carina Stegmayr; Aliaksandra Shymanskaya; Wieland A Worthoff; Nuno A da Silva; Jörg Felder; Karl-Josef Langen; N Jon Shah Journal: EJNMMI Phys Date: 2020-07-29
Authors: Alexander Heinzel; Daniela Dedic; Norbert Galldiks; Philipp Lohmann; Gabriele Stoffels; Christian P Filss; Martin Kocher; Filippo Migliorini; Kim N H Dillen; Stefanie Geisler; Carina Stegmayr; Antje Willuweit; Michael Sabel; Marion Rapp; Michael J Eble; Marc Piroth; Hans Clusmann; Daniel Delev; Elena K Bauer; Garry Ceccon; Veronika Dunkl; Jurij Rosen; Caroline Tscherpel; Jan-Michael Werner; Maximilian I Ruge; Roland Goldbrunner; Jürgen Hampl; Carolin Weiss Lucas; Ulrich Herrlinger; Gabriele D Maurer; Joachim P Steinbach; Jörg Mauler; Wieland A Worthoff; Bernd N Neumaier; Christoph Lerche; Gereon R Fink; Nadim Jon Shah; Felix M Mottaghy; Karl-Josef Langen Journal: Cancers (Basel) Date: 2022-07-08 Impact factor: 6.575
Authors: Sebastian Regnery; Nicolas G R Behl; Tanja Platt; Nina Weinfurtner; Paul Windisch; Katerina Deike-Hofmann; Felix Sahm; Martin Bendszus; Jürgen Debus; Mark E Ladd; Heinz-Peter Schlemmer; Stefan Rieken; Sebastian Adeberg; Daniel Paech Journal: Neuroimage Clin Date: 2020-09-12 Impact factor: 4.881